Effect of ion-pairing and enhancers on scutellarin skin permeability

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 4, 2008, Pages 429-435

  Wang, Manli ^a,b   Fang, Liang ^a   Ren, Changshun ^a   Li, Ting ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; DIETHANOLAMINE; DIETHYLAMINE; ETHANOLAMINE; LAUROCAPRAM; MENTHOL; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID; SCUTELLAREIN; TRIETHANOLAMINE; TRIETHYLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DETERMINATION; DRUG POTENTIATION; DRUG SOLUBILITY; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN ABSORPTION; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; AMINES; ANIMALS; APIGENIN; AZEPINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOL; GLUCURONIC ACIDS; IONS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTHOL; MYRISTATES; OLEIC ACID; PERMEABILITY; PHARMACEUTIC AIDS; PYRROLIDINONES; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY;

EID: 41849138994     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.4.0004     Document Type: Article

References (41)

1. Aboofazeli, R., Zia, H., Needham, T. E. (2002) Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv. 9: 239-247
2. Auner, B. G., Valenta, C., Hadgraft, J. (2003) Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid. Int. J. Pharm. 255: 109-116
3. Behl, C. R., El-Saved, A. A., Flynn, G. L. (1983) Hydration and percutaneous absorption IV: influence of hydration on n-alkanol permeation through rat skin; comparison with hairless and Swiss mice. J. Pharm. Sci. 72: 79-82
4. Cao, F., Guo, J., Ping, Q. (2005) The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes. Drug Dev. Ind. Pharm. 31: 747-756
5. Cao, F., Guo, J. X., Ping, Q. N., Shao, Y., Liang, J. (2006) Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamine ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats. Eur. J. Pharm. Sci. 29: 385-393
6. Cui, J. M., Fang, G., Duan, Y. B., Liu, Q., Wu, L. P., Zhang, G. H., Wu, S. (2005) Total synthesis of scutellarin-7-O-Glucuronide. J. Asian Nat. Prod. Res. 7: 655-660
7. Diez-Sales, O., Watkinson, A. C., Herraez-Dominguez, M., Javaloyes, C., Hadgraft, J. (1996) A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone. Int. J. Pharm. 129: 33-40
8. Fang, L., Kobayashi, Y., Numajiri, S., Kobayashi, D., Sugibayashi, K., Morimoto, Y., (2002) The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol. Pharm. Bull. 25: 1339-1344
9. Fang, L., Numajiri, S., Kobayashi, D., Morimoto, Y. (2003) The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int. J. Pharm. 262: 13-22
10. Femenia-Font, A., Balaguer-Fernández, C., Merino, V., Rodilla, V., López-Castellano, A. (2005) Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur. J. Pharm. Biopharm. 61: 50-55
11. Fujii, M., Takeda, Y., Yoshida, M., Utoguchi, N., Matsumoto, M., Watanabe, Y. (2003) Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int. J. Pharm. 258: 217-223
12. Ge, Q. H., Zhou, Z., Zhi, X. J. (2003) Study on pharmacokinetics and absolute bioavailability of scutellarin in dogs. Zhong Guo Yi Yao Gong Ye Za Zhi 34: 618-620
13. Goodman, M., Barry, B. W. (1985) Differential scanning calorimetry (DSC) of human stratum corneum: effect of Azone. J. Pharm. Pharmacol. 37 (Suppl.): 80P
14. Hadgraft, J. (1999) Dermal and transdermal drug design. Int. J. Pharm. Med. 13: 155-158
15. Hadgraft, J., Walters, K. A., Wotton, P. K. (1985) Facilitated transport of sodium salicylate across an artificial lipid membrane by Azone. J. Pharm. Pharmacol. 37: 725-727
16. Hao, X., Cheng, G., Yu, J. E., He, Y., An, F., Sun, J., Cui, F. (2005a) Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats. Pharmazie 60: 477-478
17. Hao, X., Cheng, G., Sun, J. (2005b) Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics. J. Pharm. Biomed. Anal. 38: 360-363
18. Heard, C. M., Johnson, S., Moss, G., Thomas, C. P. (2006) In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana. Int. J. Pharm. 317: 26-31
19. Hinz, R. S., Lorence, C. R., Hodson, C. D., Hansch, C., Hall, L. L., Guy, R. H. (1991) Percutaneous penetration of para-substituted phenols in vitro. Fundam. Appl. Toxicol. 17: 575-583
20. Hu, X. M., Zhou, M. M., Hu, X. M., Zeng, F.D. (2005) Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol. Sin. 26: 1454-1459
21. Huang, J. M., Wengm W, Y., Huang, X. B., Ji, Y. H., Chen, E. (2005) Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats. Eur. J. Drug Metab. Pharmacokinet. 30: 165-170
22. Jiang, H. Q., Li, S. H., Lan, K. (2003) Study on the pharmacokinetics of scutellarin in dogs. Yao Xue Xue Bao 38: 371-373
23. Li, S. H., Jiang, H. Q., Yang, Q. (2003) Pharmacokinetics of scutellarin in rabbits. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20: 692-694
24. Liu, H., Yang, X., Zhou, L., Xu, H. (2002) Study on effects of scutellarin on scavenging reactive oxygen. Zhong Cai Yao 25: 491-493
25. Liu, Y. M., Lin, A. H., Chen, H. (2003) Study on pharmacokinetics of scutellarin in rabbits. Yao Xue Xue Bao 38: 775-778
26. Lo, W. L., Guo, J.X., Ping, Q. N., Li, J., Zhao, C. W., Zhang, L. (2006) Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs. Yao Xue Xue Bao 41: 24-29
27. Lv, W., Guo, J., Li, J., Wang, X., Li, J., Ping, Q. (2006) Preparation and pharmacokinetics in rabbits of breviscapine unilamellar vesicles. Drug Dev. Ind. Pharm. 32: 309-314
28. Obata, Y., Hatta, I., Ohta, N., Kunizawa, N., Yagi, N., Takayama, K. (2006) Combined effects of ethanol and L-menthol on hairless rat stratum corneum investigated by synchrotron X-ray diffraction. J. Control. Release 115: 275-279
29. Ongpipattanakul, B., Burnette, R. R., Potts, R. O., Francoeur, M. L. (1991) Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8: 350-354
30. Sarveiya, V., Templeton, J. F., Benson, H. A. E. (2004) Ion-pairs of ibuprofen: increased membrane diffusion. J. Pharm. Pharmacol. 56: 717-724
31. Sarveiya, V., Templeton, J. F., Benson, H. A. E. (2005) Effect of lipophilic counter-ions on membrane diffusion of benzydamine. Eur. J. Pharm. Sci. 26: 39-46
32. Scheuplein, R. J., Blank, I. H. (1971) Permeability of the skin. Physiol. Rev. 51: 702-747
33. Sugibayashi, K., Nakayama, S., Seki, T., Hosoya, K., Morimoto, Y. (1992) Mechanism of skin penetration-enhancing effect by laurocapram. J. Pharm. Sci. 81: 58-64
34. Sznitowska, M., Berner, B., Maibach, H. I. (1995) Percutaneous penetration of multipolar ions: evidence for porous transport. Int. J. Pharm. 123: 41-45
35. Sznitowska, M., Janicki, S., Williams, A. (1998) Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. J. Pharm. Sci. 87: 1109-1114
36. Trotta, M., Pattarino, F., Gasco, M. R. (1996) Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm. Acta Helv. 71: 135-140
37. Willams, A. C. (2003) Transdermal and topical drug delivery. Pharmaceutical Press, London, p. 224
38. Williams, A. C., Barry, B. W. (1992) Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9: 305-353
39. Zhang, G. H., Wang, Q., Chen, J. J., Zhang, X. M., Tam, S. C., Zheng, Y. T. (2005) The anti-HIV-1 effect of scutellarin. Biochem. Biophy. Res. Commun. 334: 812-816
40. Zhong, H. J. (2005) Study on liposome of breviscapine. Doctoral dissertation, Shenyang Pharmaceutical University. p. 27-28
41. Zhou, Q., Jiang, X., Li, K., Fan, X. (2006) Synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates. Pharmazie 61: 660-663